Skip to main content
NovartisPro UAE

Main navigation (Don Not Delete)

    Menu
  • Products
    • Cardio – Renal – Metabolic
    • Hematology
    • Neurology
    • Oncology
Login
What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published
  • Print
  • PDF
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_website_06-68.png
Image
DUB_NOV_UAE_corp_26011_KESIMPTA
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Overall Safety
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA
Reported AEs
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Long-term Safety
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
Image
DUB_NOV_UAE_corp_26011_KESIMPTA_
RWE
  • Print
  • PDF

Novartis UAE

 

This site is intended for Healthcare Professionals only. 
Adverse Event Reporting
For Adverse event reporting to UAE EDE, please contact:
Email: [email protected]
website : Services | Ministry of Health and Prevention - United Arab Emirates
For any adverse events in Abu Dhabi, please report it to
Pharmacovigilance & Drugs Education [email protected]

To Report adverse events to Novartis:
Email to [email protected]
or
Report online by visiting  https://www.report.novartis.com/
©2025 Novartis Middle East FZE

Helpful links

 

Terms of Use

Privacy Policy

Website Privacy Policy

Site Map

© 2026 Novartis